AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Revolutionizing Weight Loss: GLP-1 and GIP Medications
This chapter explores the groundbreaking FDA-approved weight loss medications, particularly focusing on GLP-1 and GIP treatments like semaglutide and terzepatide. It discusses their dual role in not only facilitating weight loss but also reshaping the psychological relationship with food, reducing cravings, and enhancing satiety. The chapter also compares these modern treatments to traditional methods, highlighting their therapeutic advantages and addressing the evolving landscape of diabetes and obesity management.